HCA Healthcare investor debate boils down to growth, cash flow, and leverage
A recent market commentary framed HCA Healthcare’s stock as neither clearly broken nor clearly cheap, pointing to steady business performance alongside concerns that can rise when debt, costs, and reimbursement pressures move against hospitals.